Latest News about Johnson & Johnson
Recent news which mentions Johnson & Johnson
Cramer's week ahead: Inauguration, earnings from Procter & Gamble and American Express
January 17, 2025
From CNBC.com News
From CNBC.com News
Zuckerberg says Biden administration pushed Meta 'super hard' to take down vaccine content
January 10, 2025
From CNBC.com News
J&J says its lung cancer drug combination keeps people alive longer
January 07, 2025
From CNBC.com News
Cramer's Lightning Round: Netflix is a buy
December 11, 2024
From CNBC.com News
SpaceX valuation surges to $350 billion as company buys back stock
December 11, 2024
From CNBC.com News
From CNBC.com News
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
October 28, 2024
From Benzinga
Tuesday's big stock stories: What’s likely to move the market in the next trading session
October 21, 2024
From CNBC.com News
Kenvue shares surge after activist Starboard takes stake
October 21, 2024
From CNBC.com News
From CNBC.com News
Cramer's week ahead: Major banks, Taiwan Semi and Netflix report as earnings season gets into full swing
October 11, 2024
From CNBC.com News
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
From Benzinga
Cramer's Lightning Round: Dell is a buy
August 26, 2024
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
July 15, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
From CNBC.com News
From CNBC.com News
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
May 01, 2024
From CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
April 29, 2024
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Monday
April 15, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.